🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel Hochhauser

Royal London Hospital

ORCID: 0000-0001-5522-9281

Also affiliated with London Cancer, University College London

Biochemistry, Genetics and Molecular BiologyHealth ProfessionsArts and Humanities

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer”.

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01604

N/A

4.0DataRank · unranked

230 citations

Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall +14 more

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Cancer Cell(2021)10.1016/j.ccell.2021.10.001

N/A

0DataRank · unranked

263 citations

Emine Hatipoglu, Marc Robert de Massy, Kevin Litchfield, Gordon Beattie, Andrew Rowan +93 more

Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses

Cell(2023)10.1016/j.cell.2023.11.005

N/A

0DataRank · unranked

65 citations

Alexander Tong, James W. Opzoomer, Rhianna O’Sullivan, Ferran Cardoso Rodriguez, Jahangir Sufi +8 more